Skip to main content
Top
Published in: Gut Pathogens 1/2020

01-12-2020 | Clostridioides Difficile | Research

Clostridioides difficile ribotype distribution in a large teaching hospital in Serbia

Authors: Miloš Korać, Maja Rupnik, Nataša Nikolić, Milica Jovanović, Tanja Tošić, Jovan Malinić, Nikola Mitrović, Marko Marković, Ankica Vujović, Sanja Peruničić, Ksenija Bojović, Vladimir Djordjević, Aleksandra Barać, Ivana Milošević

Published in: Gut Pathogens | Issue 1/2020

Login to get access

Abstract

Background

The global epidemic of nosocomial diarrhea caused by Clostridioides (Clostridium) difficile started in 2000, with high mortality rates and emergence of a new hypervirulent strain NAP1/BI/027. The aim of this study was to assess the presence of ribotype 027 and other C. difficile ribotypes in a Serbian University Hospital, compare the temporal variability of ribotypes 3 years apart, as well as to compare clinical, demographic and laboratory characteristics and disease outcome among patients infected with 027 and non-027 ribotype. This was a prospective observational cohort study addressing 4-month intervals during 2014/2015 and 2017/2018.

Results

Ribotyping was performed in 64 non-duplicate C. difficile strains. Ribotype 027 was the most prevalent, and was detected in 53 (82.8%) patients (43/45 and 10/19 patients in 2014–2015 and 2017/2018, respectively). Other detected ribotypes were 001/072 in 4 (6.3%), 002 in 4 (6.3%), 014/020 in 2 (3.1%) and 176 in 1 (1.5%) patient. The percentage of the patients infected with ribotype 027 significantly decreased during the 3-year period, from 95.6 to 52.6% (p < 0.001). Ribotype 027 infection was associated with fluoroquinolone treatment more frequently than infection with other ribotypes [33 (62.3%) vs. 2 (18.2%), p = 0.010)]. A severe C. difficile infection was diagnosed more often in patients with the detected ribotype 027 compared to those infected with non-027 ribotypes (p = 0.006). No significant difference in the mortality and recurrence rates was found between the patients infected with ribotype 027 and those infected with other ribotypes [10/53 (18.8%) vs. 2/11 (18.2%), p = 0.708, and 10/35 (28.6%) vs. 0/2 (0%), p = 1.000, respectively].

Conclusion

Clostridium difficile ribotype 027 was the most prevalent ribotype among patients in a large Serbian hospital, but there is a clear decreasing trend.
Literature
1.
go back to reference Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Society for Healthcare Epidemiology of America; Infectious Diseases Society of America Clinical Practice Guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.CrossRef Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Society for Healthcare Epidemiology of America; Infectious Diseases Society of America Clinical Practice Guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.CrossRef
2.
go back to reference O’Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology. 2009;136:1913–24.CrossRef O’Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology. 2009;136:1913–24.CrossRef
3.
go back to reference Korać M, Milošević I, Marković M, Popović N, Ilić M, Marković A, et al. Clostridium difficile infection: a Serbian single-center experience. J Infect Dev Ctries. 2015;9(2):136–40.CrossRef Korać M, Milošević I, Marković M, Popović N, Ilić M, Marković A, et al. Clostridium difficile infection: a Serbian single-center experience. J Infect Dev Ctries. 2015;9(2):136–40.CrossRef
4.
go back to reference Rupnik M, Tambic Andrasevic A, Trajkovska Dokic E, Matas I, Jovanovic M, Pasic S, et al. Distribution of Clostridium difficile PCR ribotypes and high proportion of 027 and 176 in some hospitals in four South Eastern European countries. Anaerobe. 2016;42:142–4.CrossRef Rupnik M, Tambic Andrasevic A, Trajkovska Dokic E, Matas I, Jovanovic M, Pasic S, et al. Distribution of Clostridium difficile PCR ribotypes and high proportion of 027 and 176 in some hospitals in four South Eastern European countries. Anaerobe. 2016;42:142–4.CrossRef
5.
go back to reference Predrag S, Branislava K, Nikola S, Niko R, Zorica SR, Stanković-Đorđević D. Community-acquired Clostridium difficile infection in Serbian pediatric population. Eur J Clin Microbiol Infect Dis. 2018;37(6):1061–9.CrossRef Predrag S, Branislava K, Nikola S, Niko R, Zorica SR, Stanković-Đorđević D. Community-acquired Clostridium difficile infection in Serbian pediatric population. Eur J Clin Microbiol Infect Dis. 2018;37(6):1061–9.CrossRef
6.
go back to reference Popovic N, Korac M, Nesic Z, Milosevic B, Urosevic A, Jevtovic D, et al. Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study. Eur J Clin Microbiol Infect Dis. 2018;37(4):745–54.CrossRef Popovic N, Korac M, Nesic Z, Milosevic B, Urosevic A, Jevtovic D, et al. Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study. Eur J Clin Microbiol Infect Dis. 2018;37(4):745–54.CrossRef
7.
go back to reference Šuljagić V, Miljković I, Starčević S, Stepić N, Kostić Z, Jovanović D, et al. Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case-control study. Antimicrob Resist Infect Control. 2017;6:31.CrossRef Šuljagić V, Miljković I, Starčević S, Stepić N, Kostić Z, Jovanović D, et al. Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case-control study. Antimicrob Resist Infect Control. 2017;6:31.CrossRef
8.
go back to reference Predrag S. Analysis of risk factors and clinical manifestations associated with Clostridium difficile disease in Serbian hospitalized patients. Braz J Microbiol. 2016;47(4):902–10.CrossRef Predrag S. Analysis of risk factors and clinical manifestations associated with Clostridium difficile disease in Serbian hospitalized patients. Braz J Microbiol. 2016;47(4):902–10.CrossRef
9.
go back to reference Popovic N, Korac M, Nesic Z, Milosevic B, Urosevic A, Jevtovic DJ, et al. Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection. J Infect Dev Ctries. 2015;9(10):1062–7.CrossRef Popovic N, Korac M, Nesic Z, Milosevic B, Urosevic A, Jevtovic DJ, et al. Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infection. J Infect Dev Ctries. 2015;9(10):1062–7.CrossRef
10.
go back to reference Šuljagić V, Djordjević D, Lazić S, Mijović B. Epidemiological characteristics of nosocomial diarrhea caused by Clostridium difficile in a tertiary level hospital in Serbia. Srp Arh Celok Lek. 2013;141(7–8):482–9.CrossRef Šuljagić V, Djordjević D, Lazić S, Mijović B. Epidemiological characteristics of nosocomial diarrhea caused by Clostridium difficile in a tertiary level hospital in Serbia. Srp Arh Celok Lek. 2013;141(7–8):482–9.CrossRef
11.
go back to reference Predrag S, Branislava K, Miodrag S, Biljana MS, Suzana T, Natasa MT, et al. Clinical importance and representation of toxigenic and non-toxigenic Clostridium difficile cultivated from stool samples of hospitalized patients. Braz J Microbiol. 2012;43(1):215–23.CrossRef Predrag S, Branislava K, Miodrag S, Biljana MS, Suzana T, Natasa MT, et al. Clinical importance and representation of toxigenic and non-toxigenic Clostridium difficile cultivated from stool samples of hospitalized patients. Braz J Microbiol. 2012;43(1):215–23.CrossRef
12.
go back to reference Janezic S, Rupnik M. Molecular typing methods for Clostridium difficile: pulsed-field gel electrophoresis and PCR ribotyping. Methods Mol Biol. 2010;646:55–65.CrossRef Janezic S, Rupnik M. Molecular typing methods for Clostridium difficile: pulsed-field gel electrophoresis and PCR ribotyping. Methods Mol Biol. 2010;646:55–65.CrossRef
13.
go back to reference Popescu GA, Serban R, Pistol A, Niculcea A, Preda A, Lemeni D, et al. The recent emergence of Clostridium difficile infection in Romanian hospitals is associated with a high prevalence of polymerase chain reaction ribotype 027. Balkan Med J. 2018;35(2):191–5.CrossRef Popescu GA, Serban R, Pistol A, Niculcea A, Preda A, Lemeni D, et al. The recent emergence of Clostridium difficile infection in Romanian hospitals is associated with a high prevalence of polymerase chain reaction ribotype 027. Balkan Med J. 2018;35(2):191–5.CrossRef
14.
go back to reference Aptekorz M, Szczegielniak A, Wiechuła B, Harmanus C, Kuijper E, Martirosian G. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland. Anaerobe. 2017;45:106–13.CrossRef Aptekorz M, Szczegielniak A, Wiechuła B, Harmanus C, Kuijper E, Martirosian G. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland. Anaerobe. 2017;45:106–13.CrossRef
15.
go back to reference Davies KA, Ashwin H, Longshaw CM, Burns DA, Davis GL, Wilcox MH, EUCLID study group. Diversity of Clostridium difficile ribotypes in Europe: results from the European, multicenter, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhea (EUCLID), 2012 and 2013. Euro Surveill. 2016;21(29):1–11. https://doi.org/10.2807/1560-7917.ES.2016.21.29.30294.CrossRef Davies KA, Ashwin H, Longshaw CM, Burns DA, Davis GL, Wilcox MH, EUCLID study group. Diversity of Clostridium difficile ribotypes in Europe: results from the European, multicenter, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhea (EUCLID), 2012 and 2013. Euro Surveill. 2016;21(29):1–11. https://​doi.​org/​10.​2807/​1560-7917.​ES.​2016.​21.​29.​30294.CrossRef
16.
go back to reference Freeman J, Vernon J, Pilling S, Morris K, Nicolson S, Shearman S, et al. Pan-European Longitudinal Surveillance of Antibiotic Resistance among Prevalent Clostridium difficile Ribotypes’ Study Group. Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study. Eur J Clin Microbiol Infect Dis. 2020;39(1):169–77.CrossRef Freeman J, Vernon J, Pilling S, Morris K, Nicolson S, Shearman S, et al. Pan-European Longitudinal Surveillance of Antibiotic Resistance among Prevalent Clostridium difficile Ribotypes’ Study Group. Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study. Eur J Clin Microbiol Infect Dis. 2020;39(1):169–77.CrossRef
17.
go back to reference Mihajlov K, Andreska A, Ristovska N, Grdanoska T, Trajkovska-Dokic E. Distribution of Clostridium difficile ribotypes in macedonian patients and their antimicrobial susceptibility. Open Access Maced J Med Sci. 2019;7(12):1896–9.PubMedPubMedCentral Mihajlov K, Andreska A, Ristovska N, Grdanoska T, Trajkovska-Dokic E. Distribution of Clostridium difficile ribotypes in macedonian patients and their antimicrobial susceptibility. Open Access Maced J Med Sci. 2019;7(12):1896–9.PubMedPubMedCentral
18.
go back to reference Eyre DW, Davies KA, Davis G, Fawley WN, Dingle KE, De Maio N, et al. Two distinct patterns of Clostridium difficile diversity across Europe indicating contrasting routes of spread. Clin Infect Dis. 2018;67(7):1035–44.CrossRef Eyre DW, Davies KA, Davis G, Fawley WN, Dingle KE, De Maio N, et al. Two distinct patterns of Clostridium difficile diversity across Europe indicating contrasting routes of spread. Clin Infect Dis. 2018;67(7):1035–44.CrossRef
21.
go back to reference Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis. 2012;55(8):1056–63.CrossRef Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis. 2012;55(8):1056–63.CrossRef
23.
go back to reference Aschbacher R, Indra A, Wiedermann CJ, March A, Giacon B, Mian P, et al. Predominance of Clostridium difficile 027 during a five-year period in Bolzano, Northern Italy. Infez Med. 2017;25(1):13–20.PubMed Aschbacher R, Indra A, Wiedermann CJ, March A, Giacon B, Mian P, et al. Predominance of Clostridium difficile 027 during a five-year period in Bolzano, Northern Italy. Infez Med. 2017;25(1):13–20.PubMed
25.
go back to reference Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173:1037–42.CrossRef Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173:1037–42.CrossRef
26.
go back to reference Loo V, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442–9.CrossRef Loo V, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442–9.CrossRef
27.
go back to reference McDonald L, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433–41.CrossRef McDonald L, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353:2433–41.CrossRef
28.
go back to reference Miller M, Gravel D, Mulvey M, Taylor G, Boyd D, Simor A, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis. 2010;50:194–201.CrossRef Miller M, Gravel D, Mulvey M, Taylor G, Boyd D, Simor A, et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis. 2010;50:194–201.CrossRef
29.
go back to reference Wilson V, Cheek L, Satta G, Walker-Bone K, Cubbon M, Citron D, et al. Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis. 2010;50(12):77–81.CrossRef Wilson V, Cheek L, Satta G, Walker-Bone K, Cubbon M, Citron D, et al. Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis. 2010;50(12):77–81.CrossRef
30.
go back to reference Cloud J, Noddin L, Pressman A, Hu M, Kelly C. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol. 2009;7:868–73.CrossRef Cloud J, Noddin L, Pressman A, Hu M, Kelly C. Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol. 2009;7:868–73.CrossRef
31.
go back to reference Oleastro M, Coelho M, Gião M, Coutinho S, Mota S, Santos A, et al. Outbreak of Clostridium difficile PCR ribotype 027—the recent experience of a regional hospital. BMC Infect Dis. 2014;14:209.CrossRef Oleastro M, Coelho M, Gião M, Coutinho S, Mota S, Santos A, et al. Outbreak of Clostridium difficile PCR ribotype 027—the recent experience of a regional hospital. BMC Infect Dis. 2014;14:209.CrossRef
32.
go back to reference Mitchell BG, Gardner A. Mortality and Clostridium difficile infection: a review. Antimicrob Resist Infect Control. 2012;1(1):20.CrossRef Mitchell BG, Gardner A. Mortality and Clostridium difficile infection: a review. Antimicrob Resist Infect Control. 2012;1(1):20.CrossRef
Metadata
Title
Clostridioides difficile ribotype distribution in a large teaching hospital in Serbia
Authors
Miloš Korać
Maja Rupnik
Nataša Nikolić
Milica Jovanović
Tanja Tošić
Jovan Malinić
Nikola Mitrović
Marko Marković
Ankica Vujović
Sanja Peruničić
Ksenija Bojović
Vladimir Djordjević
Aleksandra Barać
Ivana Milošević
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2020
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-020-00364-7

Other articles of this Issue 1/2020

Gut Pathogens 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.